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Ubiquitination is a post-translational modiﬁcation in which one or more 76 amino acid
polypeptide ubiquitin molecules are covalently linked to the lysine residues of target pro-
teins. Ubiquitination is the main pathway for protein degradation that governs a variety
of eukaryotic cellular processes, including the cell-cycle, vesicle trafﬁcking, antigen pre-
sentation, and signal transduction. Not surprisingly, aberrations in the system have been
implicated in the pathogenesis of many diseases including inﬂammatory and neurode-
generative disorders. Recent studies have revealed that viruses and bacterial pathogens
exploit the host ubiquitination pathways to gain entry and to aid their survival/replication
inside host cells. This review will summarize recent developments in understanding the
biochemical and structural mechanisms utilized by bacterial pathogens to interact with the
host ubiquitination pathways.
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INTRODUCTION
Discovery of the ubiquitination system follows an elegant classical
biochemistry story, culminating with the award of the 2004 Nobel
Prize in Chemistry to three contributors: Dr. Avram Hershko, Dr.
Aaron Ciechanover, and Dr. Irwin Rose. The story started with a
search for a non-lysosomal pathway for protein degradation. The
lysosome was initially given credence for the responsibility of pro-
tein turnover in a cell. However, several aspects of the lysosomal
mode of proteolysis did not ﬁt data that was emerging, and thus
a search for an alternative mechanism began. The breakthrough
came with the use of crude extracts from reticulocytes: imma-
ture red blood cells which lack lysosomes. Protein degradation
was shown to require two complementing fractions resolved from
the crude extract: one containing protease activity and the other
containing a small heat-stable protein,ATP-dependent proteolytic
factor 1 (APF-1), which stimulated proteolysis (Ciehanover et al.,
1978). Studying the mechanism of action of APF-1 led to the
discovery that this protein is in fact the polypeptide ubiquitin
(Goldstein et al., 1975; Ciehanover et al., 1978; Wilkinson et al.,
1980). Additional study led to the elucidation of the multi-enzyme
cascade which allows ubiquitin modiﬁcation of proteins, and
which ﬁrmly established the key steps involved in the ubiquitin–
proteasome system (UPS; Ciechanover et al., 1981; Hershko et al.,
1983; Reiss et al., 1989).
The UPS consists of three classes of enzymes known
as ubiquitin-activating enzymes (E1), ubiquitin-conjugating
enzymes (E2), and ubiquitin–protein ligases (E3; Figure 1).
The ubiquitination reaction is initiated when ubiquitin is acti-
vated by the ubiquitin-activating enzyme, E1. A thioester bond
forms between the active cysteine residue of E1 and the C-
terminus of ubiquitin in an ATP-dependent reaction. Following
ubiquitin activation, activated ubiquitin is transferred to a
ubiquitin-conjugating enzyme, E2 (also known as Ubc), in
another ATP-dependent reaction. Finally, with the help of a
ubiquitin–protein ligase, E3, a covalent bond is formed between
the C-terminus of ubiquitin and the ε-amino group of a lysine
residue on the protein substrate. One round of ubiquitination pro-
duces a monoubiquitinated protein. Typically, successive rounds
occur, producing a protein with a polyubiquitinated chain. Each
additional ubiquitinmoiety is attached via the internal lysine of the
previously conjugated ubiquitin molecule. There are seven lysine
residues within the ubiquitin molecule: K6, K11, K27, K29, K33,
K48, and K63, and all seven lysines can be used to link ubiqui-
tin subunits into polyubiquitin chains in vitro (Kim et al., 2007).
In vivo, the speciﬁc lysine modiﬁcation used in the polyubiqui-
tin chain translates into the fate of the protein (Figure 1). The
formation of a K48-linked polyubiquitin chain usually leads to
the substrate being targeted for proteasome degradation (Hough
et al., 1986; Ganoth et al., 1988). The formation of a K63-linked
polyubiquitin chain provides the substrate with the ability to act
as a scaffold, allowing it to assemble signaling complexes and reg-
ulate protein localization, protein kinase activation, DNA repair,
or transcription through proteasome-independent mechanisms
(Pickart, 2001; Weissman, 2001).
The E1 ubiquitin-activating enzymes are well conserved in
eukaryotes (Hershko et al., 1983; Chiu et al., 2007). For many
years it was believed that only one E1 existed in eukaryotic cells
(Zacksenhaus and Sheinin, 1990; Mcgrath et al., 1991). Recently,
however, an E1-like protein, termed E1–L2, was also found to acti-
vate ubiquitin (Chiu et al., 2007; Jin et al., 2007; Pelzer et al., 2007).
Unlike the E1 family, there are many more members of the E2 and
E3 family of proteins, with the E3 family being the largest (Her-
shko and Ciechanover, 1998). E3s play pivotal roles in deﬁning
the speciﬁcity of target proteins to be ubiquitinated. There are
two major families of E3 ubiquitin ligases; the homologous to
E6–AP carboxyl terminus (HECT) domain family and the really
interesting new gene (RING) family. The U-box family possess a
ﬁnger domain that is a close relative of the RING motif and are
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FIGURE 1 | Ubiquitin pathway. Free ubiquitin (Ub) is activated by a ubiquitin-activating enzyme (E1), using ATP to form a complex with ubiquitin. Ubiquitin is
transferred from E1 to a ubiquitin-conjugating enzyme (E2). E2 then binds to an E3 molecule, the ubiquitin–protein ligase, which allows the polymerization of
one or more ubiquitin molecules on a substrate (S) molecule. One or several ubiquitin molecules can be conjugated to a substrate, determining its cellular fate.
therefore often categorized as members of the RING family. Each
family is differentiated by their distinct sequences, structures, and
catalytic properties (Huibregtse et al., 1995; Lorick et al., 1999;
Pickart, 2001). The HECT family E3 ubiquitin ligases contain a
350-residue region that maintains a strictly conserved cysteine
residue located approximately 35 residues from the C-terminus
(Huibregtse et al., 1995; Schwarz et al., 1998). This cysteine forms
an essential thioester intermediate during catalysis (Huibregtse
et al., 1995). The RING-ﬁnger family E3 ubiquitin ligases feature
a set of cysteine and histidine residues that have a distinctive spac-
ing to stabilize their globular conformation by interacting with
two zinc ions (Lorick et al., 1999). Whereas RING ligases func-
tion as molecular scaffolds to bring E2 and the substrates into
close proximity, HECT E3s participate directly in the chemistry of
ubiquitination by accepting ubiquitin from an E2 enzyme, in the
form of a ubiquitin–thioester intermediate, and thus directly cat-
alyze protein ubiquitination (Huibregtse et al., 1995; Figure 1).
Both HECT and RING proteins can be modular, single pro-
teins, or multi-protein complexes, such as the Skp, Cullin, F-box
(SCF)-containing complexes (Ardley and Robinson, 2005).
Ubiquitin modiﬁcation of proteins is a process restricted to
eukaryotes. Consequently, all of the enzymes that act on ubiquitin
were originally believed to be conﬁned to eukaryotes. However,
given the importance of ubiquitination to such a large number
of cellular processes required for normal cell function, it is per-
haps no surprise that pathogens have developed mechanisms to
manipulate the host ubiquitin pathway to their advantage. Viruses
are known tomodulate the host antigen presentation and immune
responses by modulating the ubiquitination system (Shackelford
and Pagano, 2005; Barry and Fruh, 2006; Gao and Luo, 2006;
Lindner, 2007). It is now recognized that bacterial pathogens also
manipulate the host ubiquitination system.
UBIQUITIN MODULATING EFFECTORS PROTEINS
Many Gram-negative bacteria encode sophisticated protein secre-
tion and translocation systems to deliver bacterial virulence deter-
minants across both the bacterial and host cellmembranes into the
infected cells. These bacterial virulence factors are often referred
to as effectors due to their ability to exploit host cellular functions.
Two of the most studied transport apparatuses are the type III
and type IV secretion and translocation systems (Cornelis, 2006;
Hayes et al., 2010). The biochemical and cellular functions of these
effector proteins are subjects of intense study since they are likely
to shed light on the molecular mechanisms utilized by bacterial
pathogens to mount successful infections. In the last few years,
it is becoming increasingly evident that many of these effectors
interact with eukaryotic ubiquitination pathways to exploit host
functions regulated by ubiquitination. We designate this group of
effectors as ubiquitin modulating effectors (UME) Proteins.
E2-TARGETING UME
So far, only one example of a bacterial protein targeting a
ubiquitin-conjugating/E2 enzyme exists: OspG in Shigella ﬂexneri
(Kim et al., 2005). Shigella is the etiological agent of human bacil-
lary dysentery. Virulence is dependent on a type three secretion
system (T3SS) encoded on a 200-kb plasmid (Buchrieser et al.,
2000). Effectors encoded on the plasmid or on the chromosome
are secreted and translocated by this T3SS to enable invasion of
the colonic epithelium. Shigella is then able to induce the intense
inﬂammatory response that is characteristic of Shigella infection.
OspG is a 196 residue protein secreted by the Shigella T3SS.
A yeast two hybrid screen identiﬁed several E2 proteins as bind-
ing partners of OspG. This included UbcH5b, a component of
the SCFβ-TrCP E3 complex, which promotes ubiquitination of
phospho-IκBα and its subsequent degradation by the proteasome
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(Karin and Ben-Neriah, 2000). IκBα binds the transcription factor
NFκB, sequestering it in an inactive state in the cytoplasm. Phos-
phorylation of IκBα, by IκB kinase (IKK), allows IκBα to be ubiq-
uitinated and targeted for proteasome degradation. This releases
NFκB, allowing its translocation to the cell nucleus and the regu-
lation of genes involved in inﬂammation, immunity, cell survival,
and other pathways. OspG was shown to delay the degradation
of phospho-IκBα, and consequently reduce the transcription of
NFκB-regulated genes (Kim et al., 2005). In vivo, an ospG mutant
enhances inﬂammatory responses. Thus Shigella, by using OspG
to bind host E2 proteins, appears to reduce host inﬂammatory
responses at early time points during infection. This may allow
Shigella time to establish itself inside the host (Figure 2). An avir-
ulent Salmonella strain has also been shown to block SCFβ-TrCP
function and prevent ubiquitination of IκBα (Neish et al., 2000).
The authors hypothesized that this may be one of the mechanisms
bywhich gastrointestinalmicroﬂora are tolerated by the host. Such
a mechanism is therefore likely to be used by other bacteria to pro-
mote their colonization of a host. As OspG was also shown to bind
other E2 proteins, in addition to UbcH5b, there may be further
unknown consequences to the ubiquitination processes during
Shigella infection.
E3-TARGETING UME
SALMONELLA
Salmonella utilizes two T3SS to establish itself inside host cells;
the ﬁrst, encoded by Salmonella Pathogenicity Island-1 (SPI-
1), facilitates invasion of non-phagocytic cells, while the sec-
ond, encoded by SPI-2, enables intracellular survival and repli-
cation (Lostroh and Lee, 2001; Knodler and Steele-Mortimer,
2003). Multiple effectors are translocated through each T3SS
to exploit host cell functions, and a major focus of Salmo-
nella research is identifying and characterizing the function of
each effector.
Salmonella SopA was initially identiﬁed as a SPI-1 effector in
Salmonella dublin with a key role in the induction of enteritis
(Wood et al., 2000; Zhang et al., 2002). However, the biochemi-
cal mechanism by which SopA induced this effect was unknown.
The ﬁrst clue suggesting SopA exploits host ubiquitination path-
ways came from a yeast two hybrid screen searching for host
cellular proteins that interact with SopA. The yeast two hybrid
assay indicated SopA interacts with human RMA1 (HsRMA1), a
membrane-bound RING ubiquitin E3 ligase (Zhang et al., 2005).
Bacterial SopA was shown to be ubiquitinated and degraded by
the HsRMA1-mediated ubiquitination pathway in vitro and in a
cell culture model (Zhang et al., 2005). One consequence of SopA
ubiquitination and degradation by the proteasome appeared to
be the escape of Salmonella into the cytoplasm of HeLa cells,
where it could rapidly replicate. However, it is unclear whether
this occurs in vivo during infection since Salmonella remains
mostly within a Salmonella-containing vacuole (SCV;Knodler and
Steele-Mortimer, 2003).
The E3 ubiquitin ligase activity of SopA itself was discovered
accidentally when a mysterious banding pattern was observed in
a routine ubiquitination assay in the absence of HsRMA1 (Zhang
et al., 2006). This showed SopA possessed auto-ubiquitination
activity: a key feature of most E3 ligases. In vitro, the ubiquiti-
nation kinetics of SopA is similar to other known E3 ubiquitin
ligases (Coscoy et al., 2001; Lostroh and Lee, 2001; Matsuda et al.,
2001; You and Pickart, 2001; Yamanaka et al., 2003).
FIGURE 2 | Manipulation of host ubiquitin pathways by Shigella. IpaH9.8 acts as an E3 ligase. (A) Binding and ubiquitination of U2AF35 by IpaH9.8 targets
this splicing factor for proteasomal degradation reducing the production of chemokines and cytokines. (B) Binding to NEMO and ABIN allows Ipa9.8 to
ubiquitinate NEMO and target it for proteasomal degradation. A consequence of this is the disruption of NF-κB signaling, which is also likely to reduce the
inﬂammatory response during Shigella infection. (C) OspG can bind the E2 UbcH5b, a component of the E3 complex SCFβ-TrCP, thus inhibiting ubiquitination of
phospho-IκBα and maintaining the IκBα/NFκB complex. Again, NFκB gene transcription is reduced, decreasing the inﬂammatory response.
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Amino acid comparisons of SopA with HECT domain and
RING-ﬁnger E3s did not reveal signiﬁcant primary sequence sim-
ilarities. However, it was determined that SopA has a cysteine
residue (C753) 30 residues away from theC-terminus.Members of
the HECT family E3 ubiquitin ligases feature a strictly conserved
catalytic cysteine residue positioned approximately 35 residues
from the C-terminus (Huibregtse et al., 1995; Scheffner et al.,
1995; Dietrich et al., 1997; Hatakeyama et al., 1997; Yamamoto
et al., 1997; Bates and Vierstra, 1999; Yanase and Ishi, 1999). This
indicated SopA may also belong to this family. Biochemical assays
conﬁrmed that Cys753 is the active site of SopA for E3 ubiqui-
tin ligase activity (Zhang et al., 2006). The crystal structure of
SopA further conﬁrmed it as a mimic of eukaryotic HECT E3s
(Diao et al., 2008). SopA shares structural similarity to HECT
E3s, including the sequence of the active site loop, the bilobal
architecture, and the conformational ﬂexibility of the C lobe.
However, it also possesses many unique characteristics (Figure 3).
For example, the folding of the N and C lobes is different and the
putative substrate binding domains are in closer proximity than
most eukaryotic E3HECT ligases,whichmay indicate SopA in fact
belongs to a novel class of E3 ligases; only time will tell.
SopA was implicated in the induction of enteritis by Salmo-
nella, in part by stimulating efﬁcient polymorphonuclear leuko-
cyte (PMN) transepithelial migration (Wood et al., 2000). The
FIGURE 3 | Structures of bacterial E3 ligases. Structural mimicry of effector
proteins to E3 ubiquitin ligases. (A) Left, a representative structure of
eukaryotic HECT E3 ubiquitin ligase, Rsp5 (PDB 3OLM). Middle, effector
protein SopA from Salmonella (PDB 2QYU). Right, effector protein NleL from
E. coli O157:H7 (PDB 3NB2). HECT or HECT-like domains are colored in blue
with the catalytic cysteines shown in red spheres. The two lobes of the
eukaryotic HECT domains are connected by a ﬂexible hinge loop (green);
whereas, in SopA and NleL, the two lobes are connected by a ﬂexible hinge
helix (green). (B) Superposition of RING-ﬁnger and U-box domains of AvrPtoB
(PDB 2FD4) and NleG (PDB 2KKX) to eukaryotic RING-ﬁnger/U-box domains
from Rbx1 (PDB 1LDJ) and RING-ﬁnger 38 protein (PDB 1X4J), respectively.
(C) Novel E3 ligases. Shown are Salmonella effector SspH2 (PDB 3G06) and
Shigella effector IpaH3 (PDB 3CVR). NEL domains are colored in green with
the catalytic cysteines shown in red spheres. LRR domains are colored in
cyan. Broken line indicated disordered loop regions. Interdomain ﬂexibility
between the NEL and LRR domains is apparent between the two structures.
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catalytically inactive SopAC753S mutant strain was found to induce
signiﬁcantly less PMN transepithelial migration as compared to
wild-type Salmonella (Zhang et al., 2006). Thus, SopA E3 ligase
activity appears to play a role in SopA-mediated enteritis. The
SopA substrate(s) remain unknown. It has been postulated that
both host proteins and bacterial T3SS translocated effectors are
potential targets of SopA. Host proteins may be directly involved
inSalmonella-induced inﬂammatory responses.Alternatively, they
may regulate the activity/level of Salmonella effectors that are
involved in inducing such inﬂammation (Zhang et al., 2006).
SopA is not the only ubiquitin E3 ligase Salmonella possesses
(Figure 4). It has three others: Salmonella leucine-rich repeat pro-
tein (SlrP), Salmonella secreted protein H1 (SspH1) and SspH2
(Rohde et al., 2007). SlrP and SspH2 are found in most Salmonella
enterica strains, while SspH1 is limited to serovar Typhimurium
strain 14028s (Miao et al., 1999). SlrP, SspH1, and SspH2 were ﬁrst
identiﬁed as belonging to a group of T3SS effectors from various
human, animal, and plant pathogens that contain LPX repeats; a
subtype of the leucine-rich repeat (LRR) superfamily of protein
binding domains (Miao et al., 1999; Tsolis et al., 1999). IpaH from
Shigella (Venkatesan et al., 1991) andYopM from Yersinia (Boland
et al., 1996) also belong to this group. It was assumed LRRs were
required for protein–protein interactions, but the precise func-
tions were unclear. SspH1 and SspH2 had together been shown
to reduce mortality in calves due to reduced intestinal lesions,
although single mutants were not attenuated in this or cell cul-
ture models of invasion or replication (Miao et al., 1999). SlrP was
required for virulence in mice but not bovine models of infection
(Tsolis et al., 1999).
The discovery that Shigella IpaH9.8 was a ubiquitin E3 ligase
(Rohde et al., 2007) provided the key to the activity of SlrP, SspH1,
and SspH2. Rohde et al. (2007) conﬁrmed SspH1 as an E3 lig-
ase; endowed with the classic activities of E3 ubiquitin ligases,
i.e., the ability to remove ubiquitin from ubiquitinated UbcH5B,
to autoubiquitinate, and to polyubiquitinate HA-tagged ubiqui-
tin. SspH1 had previously been shown to localize to the nucleus
of host cells (Haraga and Miller, 2006). Here, SspH1 binds the
human serine/threonine kinase protein kinase PKN1 and leads
to NFκB inhibition and reduction in IL-8 secretion (Haraga and
Miller, 2006). PKN1was conﬁrmed as a substrate of SspH1 (Rohde
et al., 2007), and thus SspH1 appears to use its E3 activity to
down-regulate inﬂammatory responses.
Salmonella secreted proteinH2 and SlrPwere also conﬁrmed as
ubiquitin E3 ligases. SspH2 is known to localize to the cell periph-
ery, particularly to microvilli (Miao et al., 2003; Quezada et al.,
2009). This localization to areas of dynamic actin polymeriza-
tion may be through the ability of SspH2 to interact with ﬁlamin
and proﬁlin (Miao et al., 2003). So far, no role has been identi-
ﬁed for SspH2 during infection and the substrate(s) for SspH2
are unknown (Quezada et al., 2009). SlrP appears to be involved
with inducing cell death. This is achieved through modulating two
independent pathways, only one of which is dependent on SlrP E3
activity (Bernal-Bayard and Ramos-Morales, 2009; Bernal-Bayard
et al., 2010). SlrP uses cysteine residue 546 to ubiquitinate thiore-
doxin (Trx), a protein antioxidant. Ubiquitination does not appear
to target Trx for proteasome degradation. Instead, it reduces
Trx activity, leading to increase in cell death (Bernal-Bayard and
Ramos-Morales, 2009). This may be important for the escape of
FIGURE 4 | Manipulation of host ubiquitin pathways by Salmonella
enterica. Four effector proteins have been identiﬁed to be translocated into
host cells where they can act as ubiquitin E3 ligases. (A) SspH1 ubiquitinates
PKN1 in the cell nucleus which inhibits expression of NFκB-regulated genes.
(B) SlrP targets thioredoxin (TRX) to trigger cell death. (C) SspH2 binds proﬁlin
and ﬁlamin but the substrate of its E3 activity has not been identiﬁed. (D) An
unknown effector may be responsible for the ubiquitination of MHCII
receptors and their internalization, reducing CD4+ T-cell response. (E) SopA
ubiquitinates an unknown substrate, the downstream effect of which is
induction of inﬂammation. SopA is also a substrate of the host E3, HsRMA,
being targeted for proteasomal degradation. (F) AvrA and SseL both act as
DUBs. Both deubiquitinate IκBα and allow it to form an inhibitory complex
with NFκB, thus reducing transcription of NFκB genes and therefore
decreasing inﬂammatory responses.
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FIGURE 5 | Manipulation of host ubiquitin pathways byYersinia.Yersinia
translocatesYopM andYopJ into host cells. (A)YopM is an E3 ligase although
its substrate has not been identiﬁed but is likely to moderate host cell
pathways to reduce immune system function. (B)YopJ is a DUB, with the
ability to deubiquitinate TRAF2, TRAF6, and IκBα. InY. enterocolitica, the
homologous proteinYopP has been shown to deubiquitinate TAK1, TAB1,
IκBβ, and NEMO. BothYopJ andYopP therefore disrupt NFκB signaling and
reduce the inﬂammatory response.
Salmonella should the cell become unviable either through dam-
age or due to maximum numbers of Salmonella being achieved.
It is also likely to contribute to the inﬂammation associated with
Salmonella pathogenesis. The non-proteolytic use of ubiquitin by
SlrP mimics the interaction between SspH1 and PKN1, indicating
these two proteins may use a similar mechanism to manipulate
host cell proteins. SspH2 meanwhile, has been shown to synthesize
K48-linked poly-Ub chains, implying that its targets are destined
for proteasomal destruction (Levin et al., 2010).
The crystal structure of SspH2 has been determined and reveals
a two-domain arrangement (Figure 3). The N-terminal domain is
composed of 12 LRRs; the C-terminus is globular, with a unique
fold unrelated to known HECT or RING-ﬁnger E3 ligases, which
the authors termed novel E3 ligase (NEL; Quezada et al., 2009).
The LRR domain sequesters the catalytic cysteine residue of the
NEL domain thereby auto-inhibiting the ligase activity. This may
prevent cellular toxicity until SspH2 comes into contact with the
appropriate activated-E2 and its substrate, whereupon there is
a large conformational shift, reorienting the domains (Quezada
et al., 2009). A similar fold and a similar auto-inhibitory mech-
anism appears to be used by the related Shigella IpaH proteins
(Singer et al., 2008; Zhu et al., 2008), and thus likely represents a
common feature in this novel class of ubiquitin E3 ligases.
In addition to belonging to a novel group of E3s, SspH2 is fur-
ther unique in its binding of its cognate E2. Distinct from classical
E2–E3 interactions,binding between SspH2 andUbcH5 is via both
the ubiquitin and a region in theUbcH5 not previously considered
important (Levin et al., 2010). A see-saw mechanism of ubiquitin
chain synthesis has been proposed to explain the mechanism of
ubiquitin chain formation,whereby the growing ubiquitin chain is
reciprocally transferred between the E2 andE3 active sites. To grow
the chain, a new E2–Ub is recruited to SspH2–Ubn. The chain is
subsequently added to the E2–Ub, creating E2–UBn+ 1, before the
chain is passed back to SspH2.
In addition to the four E3 ligases already identiﬁed in Sal-
monella, there is the potential that further E3s are encoded on
the Salmonella chromosome. In particular, it has been shown
that Salmonella enhances the ubiquitination of human leukocyte
antigen–DR (HLA–DR). This leads to increased internalization of
MHC class II antigens, and subsequent lower expression on the
surface of antigen presenting cells, such as DCs (Lapaque et al.,
2009). Reducing the ability of cells to present antigen to CD4-
restricted T-cells, the most important T-cell subset required for
resolution of infection (Hess et al., 1996), may provide a mecha-
nism by which Salmonella can inﬂuence the initiation of adaptive
immune responses, and enhance its survival. Ubiquitination of
HLA–DR and its subsequent internalization were dependent on
the T3SS encoded by SPI-2, although no speciﬁc effector was iden-
tiﬁed to be involved (Lapaque et al., 2009). However, this does not
rule out the possibility that these or other putative effectors may
be involved, especially since, as highlighted above, the currently
known Salmonella E3 ubiquitin ligases are mimics of host E3s
and share little primary sequence similarity with their host coun-
terparts, and in the case of SlrP, SspH1, and SspH2 share little
structural homology. It will be interesting to see as more exten-
sive research is conducted on the Salmonella proteome whether
additional E3 ligases exist.
SHIGELLA
The IpaH family of proteins were originally identiﬁed as ﬁve
homologous genes carried on the virulence plasmid: IpaH1.4,
IpaH2.5, IpaH4.5, IpaH7.8, and IpaH9.8 (Hartman et al., 1990;
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Venkatesan et al., 1991). Subsequently, it was shown that there
were copies of IpaH on the Shigella chromosome which were
also secreted and translocated into host cells and important to
pathogenesis (Ashida et al., 2007), bringing the total to nine IpaH
proteins. Each IpaH protein has a variable N-terminal domain
containing six to eight LRR segments and an approximately 300-
residue C-terminal domain (CTD) that is virtually identical in all
IpaH proteins (Ashida et al., 2007). It is this CTD which carries
the E3 activity.
IpaH E3 ubiquitin ligase activity was identiﬁed in a yeast sur-
rogate model. S. ﬂexneri IpaH9.8 was shown to inhibit yeast
pheromone response signaling through ubiquitination and target-
ing of the mitogen-activated protein kinase kinase (MAPKK) Ste7
for degradation by the proteasome (Rohde et al., 2007). Identiﬁca-
tion of a conserved cysteine residue,C337 in IpaH9.8,within all the
IpaH proteins and other homologous LRR-containing bacterial
effectors, e.g., Salmonella SspH1 and Yersinia YopM characterized
this family of proteins as a novel family of bacterial E3 ubiquitin
ligases.
The two-domain architecture of IpaH and the presence of a
cysteine residue in the CTD (IpaH–CTD) suggested IpaH may
belong to the HECT E3 family. However, IpaH–CTD has no
sequence similarity with HECT domain E3s. It also lacks struc-
tural similarity with either HECT domain E3s, including Salmo-
nella SopA, or RING-ﬁnger proteins (Singer et al., 2008; Zhu
et al., 2008). Instead, the IpaH E3 ubiquitin ligase consisted
of a new all-helical fold in which the conserved and essential
cysteine residue is located in a surface-exposed ﬂexible loop
surrounded by conserved acidic residues (CXD motif; Singer
et al., 2008; Zhu et al., 2008). This fold shares similarity to the
NEL domain identiﬁed in Salmonella SspH2 (Quezada et al.,
2009). Unsurprisingly, while the cysteine residue acts as a thiol
nucleophile to catalyze ubiquitin transfer through a transthi-
olation reaction, analogous to the catalytic cysteine in HECT
E3s, other features of the reaction are different to the HECT
family. For example IpaH requires the neighboring Asp365 for
thiol-catalyzed polyubiquitin chain formation (Zhu et al., 2008).
The N-terminal domain of the protein is also inhibitory for
the auto-ubiquitination activity of the full-length IpaH9.8 with
substrate binding releasing this inhibition (Singer et al., 2008;
Seyedarabi et al., 2010).
How does the IpaH E3 ligase activity contribute to Shigella
pathogenesis? Substrates of IpaH9.8 have been identiﬁed as
U2AF35, a mammalian splicing factor, and NF-κB essential mod-
ulator (NEMO)/IKKγ (Ashida et al., 2007, 2010; Seyedarabi
et al., 2010; Figure 2). It was previously shown that IpaH9.8
binds U2AF35 and led to down-regulation of pro-inﬂammatory
chemokine and cytokine production during infection (Okuda
et al., 2005). Given that Lys48 is the predominant ubiquitin link-
age used by IpaH (Zhu et al., 2008), it is likely that U2AF35 is
targeted for degradation and falling levels of this splicing factor
prevent production of mRNA which can be translated. Interest-
ingly, it has been discovered that IpaH9.8–CTD can exist in vitro
as a monomer able to catalyze ubiquitination of U2AF35, and as a
dimer that does not possess this activity (Seyedarabi et al., 2010).
The dimerization of IpaH9.8–CTD occurs in response to oxidiz-
ing conditions and leads to domain swapping which switches off
IpaH9.8 E3 ligase activity. Thus it appears the activity of IpaH9.8
can be regulated in response to the level of damage of the host cell,
and may allow injured cells to remain in a benign state suitable
for bacterial survival and unable to mount an attack (Seyedarabi
et al., 2010).
NF-κB essential modulator, also known as inhibitor of NFκB
kinase (IKKγ), is the regulatory subunit of the inhibitor of
IKK complex, which activates NF-κB. IpaH9.8 interacts with
NEMO/IKKγ and A20 binding inhibitor of NF-κB (ABIN-
1), a ubiquitin-binding adaptor protein (Ashida et al., 2010).
ABIN-1 promotes IpaH9.8-mediated NEMO ubiquitination lead-
ing to proteasome degradation of NEMO and disruption of
NF-κB signaling. Thus, together with its ubiquitination of
U2AF35 it appears the main role of the IpaH9.8 E3 ligase
domain is to inhibit the inﬂammatory response, which presum-
ably allows Shigella to initiate colonization at early stages of
infection (Figure 2).
YERSINIA
Yersinia pestis is the causative agent of plague, while Yersinia ente-
rocolitica and Yersinia pseudotuberculosis cause gastrointestinal
disease. Each utilizes a T3SS to inject virulence proteins, known as
Yersinia outer proteins (Yops), into host cells to subvert their func-
tion (Cornelis, 1998). Host cells targeted by Yops are typically cells
of the immune system such as macrophages, PMNs, and dendritic
cells. Impeded in phagocytosis and signaling by the Yop proteins,
these cells fail to mount a sufﬁcient immune response to remove
the pathogen, subsequently leading to disease.
YopM is one of the six Yop effectors of Yersinia and has an
important role for virulence of Yersinia spp. (Trulzsch et al., 2004).
The size of YopM differs between different strains and serotypes
ranging from 42 to 54 kDa due to a variable number and composi-
tion of LRRs (Evdokimov et al., 2001). These LRRs give the protein
homology to Salmonella SlrP, SspH1, and SspH2 and the Shigella
IpaH proteins. YopM appears to be most similar to SspH1 since
it too seems to localize to the nucleus and co-immunoprecipitates
with kinases, in this case ribosomal s6 kinase 1 (RSK1) and PKN2
(Mcdonald et al., 2003). However, the role of this interaction is
unknown during Yersinia infection, as are other aspects of how
YopM aids in eliciting disease.
Soundararajan et al. (2010) using related Salmonella and
Shigella effectors as templates, were able to use fold identiﬁca-
tion and homology-based modeling [protein core atomic interac-
tion network (PCAIN) methodology] to distinguish the struc-
ture of full-length YopM. This conﬁrmed the presence of a
NEL domain in YopM. The YopM NEL shares the conserved
catalytic site, conserved molecular surface electrostatics, and
LRR-based auto-inhibition of E3 ligase activity found in Sal-
monella SspH2 and Shigella IpaH NELs (Soundararajan et al.,
2010, 2011). The ability of YopM to act as an E3 ligase has
not been empirically tested by biochemical means. Furthermore,
it has not been translated into a deﬁned role for YopM dur-
ing infection. However, given that the YopM homologs from
Salmonella and Shigella are involved in the proteolysis of host
HLA–DR and NEMO (see above, Figures 2 and 4) it appears
plausible that YopM may also modulate human immunity in
similar ways (Figure 5).
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PSEUDOMONAS SYRINGAE
Pseudomonas syringae pathovar tomato causes bacterial speck dis-
ease of tomato by using its T3SS to deliver about 30 effectors into
the plant cell (Buell et al., 2003). One of these effectors is AvrPtoB,
a 59-kDa protein with a modular architecture. The N-terminal
region (amino acids 1–387) is recognized by the Pto kinase in
tomato varieties that are immune to speck disease. Pto interacts
with the resistance (R) protein Prf and upon binding of AvrPtoB
activates the hypersensitive response (HR): an event characterized
by rapid, localized programmed cell death (PCD), and which ulti-
mately limits pathogen growth. The CTD of AvrPtoB (comprising
amino acids 308–553) has anti-PCD activity, and this is correlated
with the ability of this domain to act as an E3 ligase (Abramovitch
et al., 2006). AvrPtoB–CTD exhibits homology to the eukaryotic
RING-ﬁnger and U-box families of proteins, and includes con-
servation of a core fold and a spatially clustered three-amino acid
surface patch required for E2-binding (Figure 3). Such a structure
suggested AvrPtoB may function as a mimic of host E3 ubiqui-
tin ligases, which was subsequently demonstrated biochemically
(Abramovitch et al., 2006).
There appear to be two distinct mechanisms that lead to
AvrPtoB-mediated PCD (Figure 6). The ﬁrst, mentioned above,
is dependent on both the Pto and Prf proteins in resistant tomato.
AvrPtoB has been shown unable to suppress PCD via this path-
way (Pedley and Martin, 2003). The second mechanism, termed
“resistance suppressed by AvrPtoB C-terminus” (Rsb), is Pto-
independent and is speculated to involve another putative resis-
tance protein and Prf. It was shown by Janjusevic et al. (2006)
that in plants lacking Pto and Prf, infection with a mutant of
AvrPtoB that lacks E3 activity triggers the HR response, i.e., it
can no longer suppress the Rbs response. This indicated that a
likely substrate for AvrPtoB was the putative resistance protein
FIGURE 6 | Manipulation of plant cell ubiquitin pathway by bacterial
pathogens. (A) Pseudomonas syringae uses the E3 effector AvrPtoB to
suppress plant innate immunity responses. AvrPtoB targets the cytoplasmic
domains of the receptor-like kinases (RLKs) FLS2 and CERK1 for degradation,
preventing downstream signaling which activates plant programmed cell
death (PCD) responses. AvrPtoB also prevents PCD by inhibiting the Rbs
response; AvrPtoB binds and speciﬁcally ubiquitinates Fen kinase, promoting
its degradation in a proteasome-dependent manner. (B) Agrobacterium
tumefaciens translocates VirF, an F-box protein, into host cells to enable
genetic transformation of the host cell. VirF can bind VIP1, a host protein
incorporated into theT-complex by bacterial effector VirE2. VirF through
binding ASK1 is incorporated into an SCF complex. Consequently, VIP1 is
ubiquitinated by the SCF complex and it and any bound VirE2 are targeted for
proteasomal degradation. This is proposed to releaseT-DNA from the
DNA–protein complex, allowing it to be integrated into the host chromatin,
completing transformation.
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that leads to Rsb-mediated PCD. The Pto family member, Fen
kinase, was subsequently found to fulﬁll this role and to physically
interact with AvrPtoB1–387 (Rosebrock et al., 2007). The AvrPtoB
E3 ligase speciﬁcally ubiquitinates Fen, promoting its degrada-
tion in a proteasome-dependent manner and leading to disease
susceptibility in Fen-expressing tomato lines (Rosebrock et al.,
2007).
Plant innate immunity relies on a subset of receptor-like
kinases (RLKs) called pattern recognition receptors (PRRs),which
respond to ligands known as pathogen-associated molecular pat-
terns (PAMPs). For example, perception of bacterial ﬂagellin or
ﬂg22, a peptide containing the ﬂagellin epitope, is through an
induced receptor complex composed of the LRR receptor kinases
ﬂagellin-sensing 2 (FLS2) and BRI1-associated kinase 1 (BAK1).
Fungal chitin is detected by the Arabidopsis receptor kinase chitin
elicitor receptor kinase 1 (CERK1;Figure 6).UponPAMP-induced
activation, PRRs stimulate a plethora of defense responses, one of
which is the MAP kinase activation discussed above. AvrPtoB has
nowalso been found to target the cytoplasmic domains of RLKs for
degradation (Gohre and Robatzek, 2008; Gimenez-Ibanez et al.,
2009). AvrPtoB associates with FLS2 via its N-terminal domain
while it uses the E3 ligase activity of its C-terminal to preferentially
target activated FLS2 for degradation (Gohre andRobatzek, 2008).
AvrPtoB also ubiquitinates the CERK1 kinase domain in vitro and
targets CERK1 for degradation in vivo (Gimenez-Ibanez et al.,
2009). Since the RLK/Pelle gene family, which includes the known
targets of AvrPtoB, makes up 60% of kinases in plants, there are
likely to be further potential targets of AvrPtoB within plants.
It may also suggest that AvrPtoB targets the plant proteome
somewhat non-speciﬁcally (Gimenez-Ibanez et al., 2009).
ENTEROHEMORRHAGIC ESCHERICHIA COLI
Enterohemorrhagic Escherichia coli (EHEC) causes bloody diar-
rhea and hemolytic uremic syndrome (HUS). EHEC possesses a
T3SS encoded by a region of its chromosome termed the locus
of enterocyte effacement (LEE). Effectors encoded in LEE, and
also a large number of additional non-LEE-encoded (Nle) effec-
tor proteins, are transmitted by the T3SS into host cells,where they
interfere with host cellular processes to induce disease. In part this
includes subverting actin polymerization to form a “pedestal” on
the host cell surface which facilitates adherence and colonization
of the pathogen, and leads to attaching and effacing (A/E) lesions.
NleG is one recently identiﬁed Nle effector, with 24 homologs
identiﬁed (mainly in the genomes of pathogenic E. coli and Sal-
monella). This group of proteins form a distinct family which
does not share any signiﬁcant sequence similarity with other pro-
teins. However, all NleG proteins contain a conserved region of
∼100 residues localized to the C-terminus. Analysis of this region
showed the presence of a motif similar to RING-ﬁnger/U-box
domains, and was shown to act as a functional E3 ligase in the
presence of ubiquitin, E1 and E2 (UBE2D2; Wu et al., 2010). E2
interacts with NleG effectors following the general architecture
established for E2/eukaryotic RING-ﬁnger complexes. Indeed,
there is signiﬁcant structural similarity between NleG and the
CTD of AvrPtoB from P. syringae (Figure 3), further indicat-
ing NleG may function in part as an E3 ligase (Wu et al.,
2010). However, no substrate has been reported for NleG; a
major hindrance being that the N-terminal is not conserved
between NleG family members and none has an identiﬁable
substrate binding motif. The authors therefore suggest NleG
effectors may primarily associate with speciﬁc host E2 enzymes
rather than transfer ubiquitin onto a substrate protein, and in
this way manipulate the host ubiquitination pathway (Wu et al.,
2010). This is an intriguing possibility but requires much further
work to conﬁrm. Alternatively, the NleG effectors may contain
novel binding motifs or use scaffolding proteins to interact with
their substrates.
Another Nle effector has been identiﬁed in EHEC as an E3 lig-
ase: EspX7, renamed as non-Lee-encoded effector ligase (NleL)
to reﬂect its novel biochemical activity (Piscatelli et al., 2011).
This effector was identiﬁed as an E3 ligase given its similarity
to SopA from Salmonella (Zhang et al., 2006; Lin et al., 2011).
Similar to SopA, NleL contains a protease-sensitive N-terminus,
a β-helix domain, and a C-terminal catalytic domain that resem-
bles the bilobal architecture of eukaryotic HECT E3s (Figure 3).
The ubiquitin ligase activity of NleL is dependent upon a cys-
teine residue (Cys753) that forms an intermediate with ubiquitin
through a thioester bond, thus NleL, like SopA, acts as a bacterial
mimic of eukaryotic HECT E3s (Lin et al., 2011; Piscatelli et al.,
2011).
In vitro ubiquitination assays show NleL preferentially forms
unanchored polyUb chains using Lys6 and Lys48 linkages. This
suggests NleL plays a role in moderating signaling pathways rather
than targeting proteins for degradation, and is supported by the
observation that NleL E3 ubiquitin ligase activity is involved
in modulating Tir-mediated pedestal formation (Piscatelli et al.,
2011). Interestingly, an EHEC mutant strain deﬁcient in E3 lig-
ase activity induced more pedestals than the wild-type strain. It
therefore appears that EHEC may use speciﬁc effector proteins to
ensure there is control in the manipulation of host pathways so a
balance is achieved between bacterial and cell survival. Consistent
with the hypothesis that unregulated pedestal formation may alter
disease, it was demonstrated that the Citrobacter rodentium NleL
homolog, which also acts as an E3 ubiquitin ligase, was required
for efﬁcient infection of murine colonic epithelial cells in vivo (Pis-
catelli et al., 2011). So far the target of NleL is unknown. It appears
Tir is not ubiquitinated by NleL (Piscatelli et al., 2011), and thus
it is reasonable to suppose that NleL ubiquitinates an unknown
bacterial or host protein(s) involved in pedestal formation, with a
decrease in protein level or an alteration in localization resulting
in a check in pedestal formation.
LEGIONELLA
The Legionella chromosome encodes a Dot/Icm type IV secretion
system (T4SS) which is essential for a number of virulence traits,
including replication within host cells (Segal et al., 1998; Vogel
et al., 1998). In Legionella infections, it has been shown that anti-
polyubiquitin antibodies decorate Legionella-containing vacuoles
(LCVs), suggesting a signiﬁcant amount of polyubiquitinated
proteins exist on LCVs (Dorer et al., 2006). As the proteasome
inhibitor MG132 was reported to adversely affect the intracellu-
lar growth of Legionella in mouse macrophages, it appears that
Legionella may be an additional pathogen that exploits the host
UPS (Dorer et al., 2006).
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In a search for novel translocated effectors of Legionella,
Lpg2830 was identiﬁed (Kubori et al., 2008). Lpg2830 contains
two-domains with striking similarity to U-boxes (U-box 1 and
U-box 2), and therefore was named LubX (Legionella U-box pro-
tein). LubX was shown to exhibit E3 ligase activity in vitro, and
required U-box 1 for this activity (Kubori et al., 2008). U-box 2
was shown to play a non-canonical role, being required for bind-
ing of the LubX substrate: Cdc2-like kinase 1 (Clk1). Clk kinases
phosphorylate serine/arginine-rich proteins (SR proteins), which
in turn modulate alternative splicing-site selection (Prasad et al.,
1999; Schwertz et al., 2006). Clk1 is shown to be required for the
growth of Legionella in macrophages, indicating Legionella targets
this host protein during infection. While it was demonstrated that
LubXdoes indeed polyubiquitinateClk1, it was not clearwhat type
of linkagewas used andwhether Clk1was targeted for degradation
(Kubori et al., 2008).
More recently, it has been shown that another substrate of LubX
is the Legionella effector protein SidH (Kubori et al., 2010). SidH
levels within host cells were shown to decline over time and were
concurrent with increasing levels of LubX. It was then shown that
LubX can bind SidH and direct its ubiquitination, targeting it for
degradation by the proteasome (Kubori et al., 2010). This is the
ﬁrst example of a bacteria effector targeting and regulating another
bacterial effector within host cells, and the authors have desig-
nated such an effector as a “metaeffector.” When it is considered
that Legionella possesses 275 conﬁrmed Dot/Icm substrates (Zhu
et al., 2011), it is perhaps not surprising that some of these may
be utilized to coordinate the function of other effector proteins
and ensure the infection proceeds as desired by the bacterium.
It will not only be interesting to uncover further metaeffectors
in the Legionella effector repertoire but to determine what other
metaeffectors are used by other bacteria, if at all.
F-BOX PROTEINS
In addition to U-boxes, it is known that proteins containing F-
boxes have an important role in protein ubiquitination. The F-box
motif is ∼50 amino acids long, although with only a few con-
served residues, and mediates protein–protein interactions. F-box
proteins form one of the constituents of the SCF complex, a multi-
protein E3 ubiquitin ligase (Zimmerman et al., 2010). The SCF
complex works in the following way to target proteins for protea-
somal degradation. Firstly, F-box proteins bind independently to a
target protein via the variable protein–protein interaction domain.
S-phase kinase-associatedprotein 1 (Skp1) binds the F-boxprotein
via the F-box motif and in this way targets the substrate recogni-
tion component of the complex to the scaffold protein Cullin-1.
Cullin-1 links the Skp domain with the RING-ﬁnger domain of
Rbx1/Roc1/Roc2. This allows ubiquitin to be passed from the E2
molecule, bound to Rbx1, to the target protein bound by the F-box
containing protein.
AGROBACTERIUM
One of the ﬁrst bacterial F-box proteins identiﬁed was VirF, from
the plant pathogen Agrobacterium tumefaciens. A. tumefaciens
genetically transforms plants during infection leading to the for-
mation of crown galls, which are essentially plant tumors. Genetic
transformation is achieved by transporting a single-stranded copy
of the bacterial transferredDNA (T-DNA) from theA. tumefaciens
tumor-inducing (Ti) plasmid into the plant cell nucleus followed
by integration into the host genome (Gelvin,2000).During genetic
transformation, virulence (Vir) proteins are also transferred into
the host cell, many of which play a role in mediating T-DNA inte-
gration. VirE2, associates with T-DNA to create a nucleoprotein
complex (T-complex; Citovsky et al., 2007), and through its asso-
ciation with the host VIP1 protein facilitates nuclear import of the
T-complex. Before integration into the host genome, the T-DNA
must be uncoated from its cognate proteins. VirF, an F-box pro-
tein, had been shown to bind the plant homolog of Skp1, ASK 1
(Schrammeijer et al., 2001). As part of the Skp1–Cdc53/Cullin–F-
box (SCF) complex, VirF has been shown to bind VIP1, thereby
targeting both VIP1 and its associated VirE2 for proteasomal
degradation (Figure 6). This leads to the release of T-DNA from
the DNA–protein complex, allowing it to be integrated into the
host chromatin (Tzﬁra et al., 2004).
Interestingly,VirF is not required for genetic transformation of
some plant species (Hirooka et al., 1987). Instead, the VirF func-
tion is performed by a host plant protein(s). The F-box protein,
VIP1-binding F-box (VBF), has recently been identiﬁed as fulﬁll-
ing this role (Zaltsman et al., 2010). VBF recognizes and binds
VIP1 and its associated VirE2, forming ternary VBF–VIP1–VirE2
complexes. VBF can then act to destabilize both VIP1 and VirE2
via the SCF–VBF pathway (Zaltsman et al., 2010). Thus, Agrobac-
terium subverts a host defense pathway induced in response to
infection, to facilitate infection.
RALSTONIA
Ralstonia solanacearum is another plant pathogen that appears to
utilize F-box proteins during infection. A group of seven genes
with homology to plant-speciﬁc LRRs have been identiﬁed and
named GALA proteins after a conserved GAxALA sequence in
their LRR (Cunnac et al., 2004). These seven GALA family effec-
tors have been shown to contain F-box motifs in their N-terminus
andmediate binding to host Skp1proteins,ASK1 andASK2 inAra-
bidopsis (Angot et al., 2006). Thus, GALA family proteins function
as SCF E3s, and this was shown to be important for virulence of
Ralstonia. A mutant in which all of the seven GALA genes were
deleted or mutated did not cause wilt in Arabidopsis, and slowed
the progression of wilting in tomato (Angot et al., 2006).
LEGIONELLA
Of human pathogens, all strains of Legionella pneumophila
sequenced to date encode multiple genes with predicted F-box
motifs, including three F-box genes in L. pneumophila strain Paris
(Lomma et al., 2010) and ﬁve F-box genes in L. pneumophila strain
Philadelphia-1 (Ensminger and Isberg, 2010). Since single, dou-
ble, and triple F-box mutations in the Paris strain F-box genes
have been shown to cause impaired intracellular replication and
defective colonization of the lungs of A/J mice, it indicates F-
box proteins and their potential interactions with host ubiquitin
pathways are important to Legionella infection (Lomma et al.,
2010).
The L. pneumophila F-box containing proteins have a struc-
ture that mimics that of their eukaryotic homologs, with an
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N-terminal F-box domain and a second C-terminal protein inter-
action motif. However, they are unique in that the second inter-
action domain is neither a WD40 repeat, nor a LRR region as
reported for eukaryotic F-box proteins (Skaar et al., 2009a,b).
One F-box protein in particular has been studied due to its con-
servation between Legionella strains: AnkB (Lpg2144) in strain
AA100/130b, LegAU13 in the Philadelphia-1 strain, and Lpp2082
in the Paris strain. AnkB has been shown to interact with Skp1.
The target of the Skp1–Cullin–AnkB complex was found to be
ParvB (Lomma et al., 2010). ParvB belongs to the Parvin family
of proteins that are involved in linking integrins and associated
proteins with intracellular pathways that regulate actin cytoskele-
tal dynamics and cell survival. Overexpression of AnkB in A549
cells and infection with L. pneumophila wild-type, but not the
ankB mutant strain, decreased ubiquitination of ParvB (Lomma
et al., 2010). It appears that AnkB inhibits the endogenous ubiq-
uitin ligase of ParvB perhaps by competing for the interaction
site (Lomma et al., 2010). The authors also hypothesized that
by decreasing ubiquitination of ParvB, AnkB might stabilize the
integrin-linked kinase (ILK)–PINCH–ParvB complex leading to
caspase-3 activation and apoptosis. Alternatively, ParvB may act
as an accessory protein to direct AnkB to the plasma membrane,
where the E3 ligase activity of SCF directs the ubiquitination of
one ormore additional proteins. Since inhibition of ParvB by RNA
interference resulted in reduced intracellular growth of L. pneu-
mophila, this reveals a new mechanism by which L. pneumophila
may employ translocated effector proteins to promote bacterial
survival.
Another Legionella F-box protein, LegU1 (Lpg0171), has also
been shown to form a complex with both Skp1 and Cullin, and to
therefore possess E3 ligase activity (Ensminger and Isberg, 2010).
Using a two-step enrichment strategy in which immunoprecipi-
tates of 3XFLAG-tagged LegU1 were subjected to a second round
of immunoprecipitation to isolate ubiquitinated species, HLA–B-
associated transcript 3 (BAT3) was identiﬁed as a target of the
SCF–LegU1 complex (Ensminger and Isberg, 2010). The translo-
cated Legionella effector, Lpg2160,was also found to associate with
the SCF–LegU1–BAT3 complex although it does not get ubiqui-
tinated. As two Legionella effectors target BAT3, it appears that
modulation of BAT3 activity is crucial during Legionella infection.
BAT3 plays a role in the ER stress response and host apoptotic
pathways (Desmots et al., 2008; Tsukahara et al., 2009), thus,
LegU1 and Lpg2160 may interfere with BAT3 function to miti-
gate the effects of disrupting normal vesicular trafﬁcking in the
host cell.
LicA, is a third translocated L. pneumophila Philadelphia effec-
tor with an F-box motif. While it associates with Skp1 it does so
in the absence of Cullin1, and lacks auto-ubiquitination activity.
This suggests LicA does not form an E3 ligase, but may also sug-
gest the ability of LicA to form a non-canonical SCF complex using
alternate eukaryotic components (Ensminger and Isberg, 2010).
CRYPTOCOCCUS
Another human pathogen utilizing an F-box protein is Crypto-
coccus neoformans, the leading cause of fungal meningitis in the
immunocompromised. Fbp1 in C. neoformans contains a putative
F-boxdomain and12LRRs andphysically interactswith Skp1, sug-
gesting it may function as part of a SCF E3 ligase (Liu and Shen,
2011). As Fbp1 is essential for C. neoformans virulence, this indi-
cates the SCF E3 ubiquitin ligase-mediated proteolysis pathway
is likely to be important during infection, although its substrates
remain to be identiﬁed.
NON-PATHOGENIC BACTERIA
F-box proteins are not only associatedwith pathogens. The amebal
symbiont Amoebophilus asiaticus encodes 15 proteins with pre-
dicted F-boxmotifs and 9 proteinswith E3 ligase-associatedU-box
domains in its chromosome, indicating it too may interfere with
the host ubiquitination system (Schmitz-Esser et al., 2010).
DE-UBIQUITINATING UME
In addition to being able to moderate the activities of a pro-
tein by adding ubiquitin, the removal of ubiquitin can also be
a powerful tool to control cellular functions. De-ubiquitinating
enzymes (DUBs) cleave the isopeptide bond between ubiquitin
and its target protein. This produces free ubiquitin which can then
be recycled by the cell. Thus, ubiquitination is a reversible post-
translational modiﬁcation, and as such, is often compared to the
post-translational modiﬁcation of phosphorylation. Both modi-
ﬁcations require ATP, are irreversible and alter the recognition of
proteins by the cell (Orth, 2002). Since bacteria have evolved to
possess effectors with the ability to modify proteins with ubiqui-
tin, it is not surprising that they have also evolved effectors that
act as DUBs.
YERSINIA
Yersinia effector YopJ (YopP in Y. enterocolitica), is essential for the
ability of Yersiniae to kill macrophages and to establish a systemic
infection in mice (Monack et al., 1998). YopJ appears to have sev-
eral activities in infected cells that contribute to its importance to
establish infection. YopJ inhibits the pro-inﬂammatory mitogen-
activated protein kinase (MAPK) and NFκB pathways (Palmer
et al., 1998; Ruckdeschel et al., 1998; Schesser et al., 1998), both of
which play roles in innate and adaptive immunity.Yersinia appears
to target both pathways to reduce the inﬂammatory response
during infection; the production of protective cytokines, such
as tumor necrosis factor-α (TNF-α) and IL-8, are inhibited, and
apoptosis in macrophages is induced. Sequence analysis of YopJ
showed no homology to known proteins, but secondary structure
analysis indicated similarity to adenovirus protease (AVP; Orth
et al., 2000). A conserved catalytic cysteine was identiﬁed between
these two proteins, mutation of which in YopJ abolishes its ability
to inhibit the MAPK and NFκB pathways, and inhibit TNF-α pro-
duction (Orth et al., 2000). Thus, the protease activity of YopJ is
key to its function.
Adenovirus protease had been indicated to resemble the cys-
teine protease, ubiquitin-like protein protease 1 (Ulp1) in yeast (Li
and Hochstrasser, 1999), which is able to remove small ubiquitin-
relatedmodiﬁer (SUMO) frommodiﬁed proteins.YopJwas shown
by Orth et al. (2000) to share this activity. Overexpression of YopJ
in 293 cells results in a decrease in proteins bound to SUMO.
This activity of YopJ has been questioned by Zhou et al. (2005)
who found that YopJ did not deSUMOlyate proteins. However,
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both authors agree that YopJ possesses deubiquintation activity,
dependent on cysteine 172, and as such was the ﬁrst bacter-
ial effector shown with this property (Orth, 2002; Zhou et al.,
2005).
YopJ appears to be a potent de-ubiquitinating protease, being
able to cleave ubiquitin moieties from many substrates includ-
ing TNF receptor-associated factor 2 (TRAF2), TRAF6, NF-
κB-inducing kinase (NIK), and IκBα (Figure 5). TRAF2 and
TRAF6 undergo auto-ubiquitination and acquire K63 polyubiq-
uitin chains which are proposed to promote the assembly of a
multi-protein complex that activates the IKK complex and hence,
NF-κB signaling. YopJ can remove both K48 and K63 linkages.
By reversing the ubiquitination of TRAF2, TRAF6 and/or phos-
phorylated IκBα during Yersinia infection, YopJ maintains the
IκB–NFκB complex. This keeps NFκB sequestered in the cyto-
plasm thereby attenuating the NFκB pathway which is observed
during wild-type Yersinia infections (Figure 5). Y. enterocolitica
YopP has also been shown to bind and deubiquitinate IKKb,
TRAF6, and NEMO in vitro (Carter et al., 2003; Haase et al.,
2005). However, Thiefes et al. (2006) reported TRAF6 was not
deubiquitinated by YopP but rather TAK1 and TAB1 are deu-
biquitinated, inhibiting TAK1 autophosphorylation and activ-
ity (Thiefes et al., 2006). There is no evidence that MAPKKs
require ubiquitin or SUMO conjugates for activation, and thus
it was not clear how YopJ/P could suppress the MAPK path-
way simultaneously with the NFκB pathway. By placing the
inhibitory mechanism of YopP at TAK1, i.e., downstream from
TRAF6 and upstream from MAPKK6/p38 MAPK, it does pro-
vide a mechanism whereby YopJ/P can activate both the MAPK
and NFκB pathways to down-regulate innate immune signaling.
However, it is unclear whether these observations are speciﬁc to
the IL-1 activation pathway or universal. Recently an alterna-
tive mechanism by which YopP/J suppresses the two pathways
has been identiﬁed: YopJ acts not only as a DUB but as an
acetyltransferase (Mittal et al., 2006; Mukherjee et al., 2006).
YopJ binds and acetylates critical serine or threonine residues,
using acetyl-coenzyme A (CoA), in the activation loop of MAP-
KKs and IKKb, respectively. This prevents these residues from
being phosphorylated and from being activated, blocking signal-
ing through the MAPKK and NFκB pathways (Mukherjee et al.,
2006). Inositol hexakisphosphate (IP6) acts as an activation cofac-
tor for YopJ acetyltransferase activity (Mittal et al., 2006). Thus,
it appears YopJ has two different enzymatic capabilities and may
explain why Yersinia is so efﬁcient at inhibiting the MAPK and
NFκB pathways; acting on multiple components in a multitude
of ways.
SALMONELLA
Salmonella possesses two DUBs with homology to YopJ. AvrA is
encoded by the SPI-1 region of the Salmonella genome (Hardt
and Galán, 1997), and cleaves ubiquitin moieties from IκBα and
β-catenin, thus regulating both the NFκB and β-catenin signal-
ing pathways (Collier-Hyams et al., 2002; Sun and Chen, 2004;
Ye et al., 2007; Figure 4). Stabilized IκBα leads to inhibition of
NF-κB signaling and consequently inhibition of the inﬂammatory
response. Stabilization of β-catenin leads to increased β-catenin
transcriptional activity, activating cell proliferation and inhibiting
cell apoptosis (Ye et al., 2007). Like YopJ, AvrA also exhibits acetly-
transferase activity which is targeted on MAPKKs (Jones et al.,
2008). However, interestingly, AvrA is anti-apoptotic not pro-
apoptotic like YopJ and its homolog AopP of Aeromonas salmoni-
cida (Jones et al., 2008). These differences may be accounted for by
the selectivity of substrates. For example AvrA acts as a c-Jun N-
terminal kinase (JNK) inhibitor at the level of MKK4/7,preventing
JNK stimulating a pro-apoptotic response (Jones et al., 2008; Du
and Galan, 2009), while YopJ has a more promiscuous range of
MAPKK inhibitory activity (Mukherjee et al., 2006). Recently, the
number of pathways on which AvrA potentially has an impact
has been expanded to include: the p53 pathway, mTOR signaling,
oxidative phosphorylation,VEGF, and JAK-STAT (Liu et al., 2010;
Wu et al., 2010). Their roles in the anti-apoptotic function of AvrA
have yet to be characterized.
Examining Salmonella genes expressed under SPI-2 inducing
conditions led to the identiﬁcation and characterization of another
YopJ family member in Salmonella: SseL (Coombes et al., 2007;
Rytkonen et al., 2007). Biochemical assays show SseL functions as
a DUB and, like AvrA, impairs IκBα ubiquitination and degrada-
tion, suppressing NFκB activation (Le Negrate et al., 2008). This
appears important for the systemic spread of Salmonella in mice,
since by competitive index a sseL null mutant is attenuated in vir-
ulence, although no defect was observed in vitro (Coombes et al.,
2007; Rytkonen et al., 2007). However, while AvrA, through its
activity on the β-catenin pathway, inhibits apoptosis, it appears
SseL may induce cytotoxicity in macrophages at later stages of
infection (Rytkonen et al., 2007); although the importance of SseL
in this process has been challenged by Le Negrate et al. (2008)
who observed only a slight cytotoxic effect due to SseL. Since
both AvrA and SseL act on IκBα, this appears to be an impor-
tant stage at which the NFκB pathway proteins and Salmonella
effectors intersect. The activity of AvrA and SseL is consistent
with the in vivo ability of Salmonella to dampen innate immune
signaling while preventing the apoptotic elimination of infected,
compromised cells. This may allow Salmonella more extensive tis-
sue invasion, extending its long-term survival as it replicates in
viable host cells.
In additional to the Salmonella DUBs, several other bacter-
ial proteins have been discovered with similar homology to YopJ
(Table 1). This “YopJ family” includes effectors from animal and
plant pathogens and plant symbionts. Each shares a conserved cat-
alytic core, consisting of three key amino acid residues (histidine,
glutamic acid, and cysteine), and designates them as such to the
C55 family of cysteine proteases (Orth et al., 2000; Barrett and
Rawlings, 2001). Each protein appears to share at least one cat-
alytic activity prescribed to YopJ, i.e., the ability to deubiquitinate,
deSUMOlyate, or acetylate. Interestingly, Xanthomonas possesses
not onlyYopJ-like effectors which exhibit similarity to a ubiquitin-
like protein protease (Ulp1), but also the effector XopD which is
a bona ﬁde member of the Ulp1 protein family with deSUMOy-
lating activity (Hotson et al., 2003). This may suggest that after
acquiring an Ulp1/Ulp-1 like hydrolase, pathogenic bacteria have
adapted this protein to increase/modify its range of activity, thus
making it a more potent tool during pathogenesis.
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Table 1 | YopJ family members.
Bacterium Effector Activity Target(s) Role during infection Reference
Yersinia
pseudotuber-
culosis
YopJ DUB TRAF2, TRAF6
NIK, IκBα
Inhibits NFκB and MAPKK
pathways
Orth et al. (2000), Zhou
et al. (2005), Mukherjee
et al. (2006)
Acetlytransferase MAPKKs and
IKKb
Yersinia
enterocolitica
YopP DUB IKKb, TRAF6,
TAK1,TAB1,
NEMO
Inhibits NFκB and MAPKK
pathways
Carter et al. (2003), Haase
et al. (2005), Thiefes et al.
(2006)
Salmonella
enterica
AvrA DUB
Acetlytransferase
IκBα, β-catenin
MAPKKS;
MKK4/7
Inhibits NFκB and MAPKK
pathways
Collier-Hyams et al. (2002),
Sun et al. (2004), Ye et al.
(2007), Jones et al. (2008),
Du and Galan (2009)
SseL DUB IκBα Inhibits NFκB pathways Le Negrate et al. (2008)
Vibrio para-
haemolyticus
VopA Acetlytransferase MAPKKs Inhibits MAPK signaling path-
ways (but not NFκB pathway)
Trosky et al. (2004, 2007)
Aeromonas
salmonicida
AopP IκBα Inhibits NFκB pathway Fehr et al. (2006)
Xanthomonas
campestris
AvrRxv deSUMOlyation AvrRxv
interactor 1
(ARI1)
Inhibit HR response Whalen et al. (1993), Ciesi-
olka et al. (1999), Whalen
et al. (2008)
AvrXv4 deSUMOlyation Inhibit HR response Roden et al. (2004)
AvrBst deSUMOlyation SNF1-related
kinase 1
(SnRK1)
Inhibit HR response Ciesiolka et al. (1999),
Szczesny et al. (2010)
XopJ deSUMOlyation Inhibition of cell wall-based
defense responses
Noel et al. (2003), Bartetzko
et al. (2009)
Ralstonia.
solanacearum
PopP1 Lavie et al. (2002)
PopP2 Acetlytransferase RRS1-R R
protein
Stabilizes RRS1-R; elicits
RRS1-R-mediated disease
resistance in Arabidopsis
Deslandes et al. (2003),Tas-
set et al. (2010)
Pseudomonas
syringae
HopZ1 (HopPmaD) Isoﬂavone
biosynthesis
enzyme, 2-
hydroxyisoﬂavanone
dehydratase
(GmHID1)
Alfano et al. (2000), Deng
et al. (2003), Zhou et al.
(2011)
HopZ2 (AvrPpiG1) Alfano et al. (2000), Deng
et al. (2003)
HopZ3 (HopPsyV) Alfano et al. (2000), Deng
et al. (2003)
Rhizobium sp.
strain NGR234
Y4lO Symbiotic determinant
required for the formation
of functional nitrogen-ﬁxing
nodules
Yang et al. (2009)
Erwinia
amylovora
ORFB Oh et al. (2005)
CHLAMYDIA
Chlamydia trachomatis is a bacterium which possesses DUBs dis-
tinct from those of the YopJ family. Instead, the predicted cat-
alytic domains of ChlaDub1 and ChlaDub2 share similarity with
the Ulp domain of SUMO-speciﬁc proteases (SENPs), a family
of proteases that possess either deneddylating or desumoylat-
ing activities (Misaghi et al., 2006). ChlaDub1 and ChlaDub2
have been shown in vitro to hydrolyse the thioester bonds that
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attach ubiquitin and NEDD8 (a ubiquitin-like protein) to tar-
get proteins (Misaghi et al., 2006). It appears for ChlaDub1 this
translates into impairment of IκBα ubiquitination and its sub-
sequent proteasome-mediated degradation, thereby preventing
NFκB activation and potentially providing one mechanism by
which Chlamydia is able to evade immune responses and establish
long-term carrier states in infected individuals (Le Negrate et al.,
2008). Since several viruses encode DUBs (Balakirev et al., 2002;
Kattenhorn et al., 2005; Schlieker et al., 2005), it is not surprising
that Chlamydia with its similar intracellular replication cycle, has
developed tools to modulate the host ubiquitin–proteasome path-
way. Further studies into the cellular function of ChlaDub1 and
particularly ChlaDub2 will no doubt provide more information
as to how C. trachomatis uses DUBs to manipulate its host.
CONCLUSION
Many bacterial pathogens have developed sophisticated secretion
and translocation apparatus to transfer a set of proteins (effectors)
directly into the cytoplasmof thehost cell. These effectorsmanipu-
late host cellular responses, promoting the progression of bacterial
infection and pathogenesis. It appears that interfering with ubiq-
uitin signaling in the host is an important and common strategy
used by pathogens to promote their survival in the host. In many
of the examples reviewed here, exploiting the ubiquitin pathways
to evade the host immune system during the course of infection
is of particular importance to bacteria; Salmonella, Shigella, and
Yersinia all target the NFκB pathway to control the inﬂammatory
response elicited during their infection. However, while each bac-
terium may target similar pathways, in many instances they appear
to have developed different tools, and in doing so may target dif-
ferent stages in a speciﬁc host pathway. For example while Shigella
uses OspG, an E2 targeting UME, to prevent signaling through the
NFκB pathway, Salmonella and Yersinia use DUBs, albeit DUBs
which act at different stages of the pathway. Thus, while there are
many common themes in how bacteria manipulate host ubiquitin
pathways, each bacteriumhas often developed one ormore unique
effectors allowing them to exquisitely manipulate the host to suite
their particular lifestyle.
An important strategy used by bacteria to manipulate host
pathways is the use of effectors that functionally mimic eukaryotic
proteins. This is no different formoderation of the ubiquitin path-
way. Each of the major subclasses of eukaryotic E3s have bacterial
counterparts either in sequence or structure. For example SopA
structurally resembles HECT E3s and AvrPtoB resembles a RING
E3,while LubX andVirF proteins bear aU-box and an F-boxmotif,
respectively. However, the study of ubiquitin E3 ligases in bacteria
has also unearthed a new class of E3s: the NEL family, exempliﬁed
by IpaH, SspH2, and YopM (Singer et al., 2008; Zhu et al., 2008;
Quezada et al., 2009). This suggests that bacterial and eukaryotic
genomes might encode additional novel E3s that have not yet been
identiﬁed and will no doubt be an area of further study especially
as predictive and modeling software becomes more advanced. It is
also interesting that most of the bacteria carrying NEL ubiquitin
ligases are pathogenic. On the one hand this provides the inter-
esting question as to how these proteins evolved and have been
propagated between bacterial species, and on the other provides
exciting opportunities for the development of antibacterial thera-
peutics. Such therapies are likely to be particularly effective given
that NEL-containing effectors are often critical virulence deter-
minants and they currently do not have any known mammalian
homologs.
In addition to further understanding how bacteria manipu-
late host ubiquitin pathways, a fruitful area of research is likely to
be how bacteria interact with the ubiquitin-like proteins SUMO,
NEDD8, ISG-15, and FAT10. These ubiquitin-like proteins con-
tain a C-terminal di-glycine motif that can be covalently attached
to protein targets through enzymatic reaction cascades similar to
that of ubiquitination. Thus, it will not be surprising if bacteria
have also developed mechanisms to manipulate these pathways in
cells. Indeed, it has already been shown that the EPEC effector
cycle inhibiting factor (Cif) interferes with neddylation-mediated
cell-cycle control (Morikawa et al., 2010).
To conclude, the host ubiquitin pathway is carefully moder-
ated by bacteria during infection, indicating its importance to the
bacteria–host interaction, and further study will not only educate
us in mechanisms used by bacteria during pathogenesis but also
in the processes used by cells for survival and maintenance.
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